These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23418085)

  • 21. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
    Dai G; Liu P; Li X; Zhou X; He S
    Medicine (Baltimore); 2019 Feb; 98(7):e14324. PubMed ID: 30762732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
    Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
    J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
    J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.
    Bhatt SP; Nigam P; Misra A; Guleria R; Pandey RM; Pasha MA
    Metab Syndr Relat Disord; 2013 Oct; 11(5):329-35. PubMed ID: 23734760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
    Xu J; Xin YN; Lü WH; Lin ZH; Zhang DD; Zhang M; Dong QJ; Jiang XJ; Xuan SY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):619-23. PubMed ID: 24119744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
    PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
    Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.
    Alam S; Islam MS; Islam S; Mustafa G; Saleh AA; Ahmad N
    Indian J Gastroenterol; 2017 Sep; 36(5):366-372. PubMed ID: 28975533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
    Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
    World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
    Martínez LA; Larrieta E; Kershenobich D; Torre A
    Ann Hepatol; 2017 November-December,; 16(6):909-915. PubMed ID: 29055919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
    Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
    Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.